Study Details
NFX-179: A Study Drug for Cutaneous Neurofibromas
(IRB#: IRB_00147755)
NFX-179 Gel is a study drug to reduce the growth of benign tumors that grow from small nerves under the skin called cutaneous neurofibromas (cNF). Scientists and doctors do not know the safety and effectiveness of the treatment. Research is needed to learn if it may be approved and used to improve the health of people suffering from cNF.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 18+
- All genders
- In-person at Unversity of Utah
- Time commitment approx. 8 months
- Compensation up to $675
Exclusion Criteria
- Pregnant women
Will I be paid for my time?
Yes
IRB#: IRB_00147755
PI: David Viskochil
Department: DERMATOLOGY
Approval Date: 2022-02-02 07:00:00
Specialties: Pediatric Genetics